Casper W F van Eijck

7PUBLICATIONS
38CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cell physiologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 12, 2026
CD40 Agonism in Pancreatic Ductal Adenocarcinoma: Expression, Biology, and Therapeutic Targeting.

|Jan 29, 2026
Thromboembolic Events During Perioperative Therapy for Resectable and Borderline Resectable Pancreatic Cancer in the PREOPANC-2 Trial.

Ruth A L Willems, Aniek E van Diepen, Esther N Dekker

|Nov 28, 2025
REACtiVe-2: phase I evaluation of dendritic cell vaccination and agonistic CD40 therapy following (m)FOLFIRINOX in metastatic pancreatic cancer.

Songul Kucukcelebi, Freek R van 't Land, Sjoerd H van der Burg

|Dec 27, 2024
Evaluation of Photoplethysmography-Based Monitoring of Respiration Rate During High-Intensity Interval Training: Implications for Healthcare Monitoring.

Marjolein Muller, Kambiz Ebrahimkheil, Tara Vijgeboom

|Mar 15, 2024
Rintatolimod in Advanced Pancreatic Cancer Enhances Antitumor Immunity through Dendritic Cell-Mediated T-Cell Responses.

Casper W F van Eijck, Hassana El Haddaoui, Songul Kucukcelebi

|Sep 14, 2023
Enhanced antitumour immunity following neoadjuvant chemoradiotherapy mediates a favourable prognosis in women with resected pancreatic cancer.

Casper W F van Eijck, Dana A M Mustafa, Disha Vadgama

Pageof 2

Frequent Collaborators

5 joint publications

Casper H J van Eijck

3 joint publications

Dana A M Mustafa

3 joint publications

Aniek E van Diepen

3 joint publications

Songul Kucukcelebi